Do GLP-1s make birth control less effective?

Which medication carries the warning?

The two are constantly blurred together online, and the difference is not a technicality. One of these medications has a specific contraceptive instruction in its FDA labeling and the other does not.

The mechanism given in the labeling is delayed gastric emptying, which slows how quickly a swallowed pill is absorbed. The label notes that this delay is largest after the first dose and diminishes over time, which is why the advice is tied to starting and to each step up rather than to the whole time you are on treatment.

Which 4 weeks, exactly?

This is the part that gets misread, so here it is precisely. On tirzepatide, if you take an oral hormonal contraceptive, the labeling advises a non-oral method or an added barrier method:

• For 4 weeks after you start tirzepatide. The clock starts at your first dose.
• For 4 weeks after each dose increase. Every escalation restarts the 4 weeks, not just the first one.
• That means several separate windows during titration. If your dose steps up more than once, each step has its own 4 week window.
• It applies to oral hormonal contraceptives. Methods that are not taken by mouth should not be affected.

A practical way to hold this: put the date of every dose increase in your calendar with a reminder four weeks later. Dose steps are easy to lose track of during titration, and this is the one thing you do not want to lose track of.

Which methods are affected and which are not

The dividing line in the labeling is simple: is it swallowed, or is it not.

Two things sit outside the label but matter in practice. Vomiting or severe diarrhea can reduce the absorption of any swallowed pill, and both are common in the days after starting a GLP-1 or stepping up a dose, so that is a second reason backup cover is sensible in those windows. And if you are unsure whether your method counts as oral, ask, rather than working it out from a forum.

How this is handled with a provider

The reason this belongs in a clinical relationship rather than a checkout flow is that dose increases are decided by a provider, so a provider is the person who knows when your 4 week windows begin.

• A free consultation with a health specialist, with no obligation to buy
• A US-licensed provider asks what contraception you use before prescribing, and factors it into the plan
• Provider check-ins every four weeks, which is when dose changes happen and when the backup window is flagged
• Compounded tirzepatide from $332 per month ($997 for a 3-month supply), or compounded semaglutide from $199 per month ($597 for a 3-month supply), if you are prescribed one

Compounded medications are not FDA-approved. Tell your provider what contraception you use even if you think it is not relevant, and tell the clinician who prescribes your contraception that you are starting a GLP-1.

What if you already started and nobody told you?

This happens, and the useful response is a phone call rather than panic. If you have been taking an oral contraceptive through a tirzepatide start or a dose increase without backup cover:

• Start using a barrier method now, and keep using it while you get advice.
• Contact your prescriber or a pharmacist. They can tell you what applies to your specific pill and your specific timing.
• Ask about emergency contraception if you have had unprotected sex during one of those windows. It is time-sensitive, so ask today rather than tomorrow.
• Do not stop your GLP-1 on your own to fix this. The fix is the contraceptive cover, not stopping treatment abruptly.
• Take a pregnancy test if your period is late, and contact your provider promptly if it is positive, because these medications are not for use in pregnancy.

What to do if you do become pregnant, or if you are planning to, is covered on can you take a GLP-1 while pregnant or trying to conceive.

Does this apply to other pills you swallow?

Contraception is the one with a specific instruction, but it is not the only oral medication worth mentioning. Both semaglutide and tirzepatide slow gastric emptying, and the labeling for both advises caution with concomitantly administered oral medications, with particular attention to those that depend on reaching a threshold concentration or have a narrow therapeutic index.

• Tell every prescriber you have that you are on a GLP-1, including your pharmacist.
• Do not stop or adjust any medication yourself on the basis of this. It is a monitoring point, not an instruction.
• Mention it before any procedure with sedation, because delayed stomach emptying is relevant to anesthesia.
• Raise thyroid medication, anticoagulants and epilepsy medication specifically, since these are the kinds of medication where timing and levels matter most.

For the broader safety picture, see semaglutide side effects and tirzepatide side effects.

Frequently asked questions

Sources

1. Zepbound (tirzepatide) injection, Prescribing Information · U.S. Food and Drug Administration
2. Mounjaro (tirzepatide) injection, Prescribing Information · U.S. Food and Drug Administration
3. Wegovy (semaglutide) injection, Prescribing Information · U.S. Food and Drug Administration